Dash Bio, Inc. — Form D
Dash Bio, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-17. $6.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-10-17
- Form: D
- Accession: 0002041370-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $6.1M
- Investors: 15
- Date of first sale: 2024-10-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-527011
Issuer
- Name: Dash Bio, Inc.
- CIK: 0002041370
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 56 BROAD STREET STE 14011, BOSTON, MA, 02109
- Phone: 617-249-4472
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| David Johnson | Director | Greenwood Village, CO |
| David Johnson | Executive Officer | Greenwood Village, CO |
| David Johnson | Related Person | Greenwood Village, CO |
| ALEXANDER TALLETT | Director | Boston, MA |
| ALEXANDER TALLETT | Executive Officer | Boston, MA |
| ALEXANDER TALLETT | Related Person | Boston, MA |
| Andy Smith | Related Person | Boston, MA |
Other filings by this issuer (2)
More